Cefpiramide
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intravenous, intramuscular |
ATC code | J01DD11 (WHO) |
Pharmacokinetic data | |
Protein binding | 93% to 99.3% |
Biological half-life | 4.44 hours |
Excretion | Renal and fecal |
Identifiers | |
| |
CAS Number | 70797-11-4 |
PubChem (CID) | 636405 |
DrugBank | DB00430 |
ChemSpider | 552192 |
UNII | P936YA152N |
KEGG | D03428 |
ChEBI | CHEBI:59213 |
ChEMBL | CHEMBL1201204 |
Chemical and physical data | |
Formula | C25H24N8O7S2 |
Molar mass | 612.64 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Cefpiramide is a third-generation cephalosporin antibiotic.
External links
- Wang H, Yu Y, Xie X, Wang C, Zhang Y, Yuan Y, Zhang X, Liu J, Wang P, Chen M (2000). "In-vitro antibacterial activities of cefpiramide and other broad-spectrum antibiotics against 440 clinical isolates in China". J Infect Chemother. 6 (2): 81–85. doi:10.1007/PL00012156. PMID 11810540.
- Iakovlev V, Vishnevskiĭ V, Khlebnikov E, Khadin I, Plavlova M, Elagina L, Izotova G (1995). "[Cefpiramide (Tamicin) in the treatment of purulent complications of abdominal surgery]". Antibiot Khimioter. 40 (9): 30–4. PMID 8651827.
- Sampi K, Hattori M (1992). "[Comparative study of cefpiramide + amikacin versus piperacillin + amikacin in granulocytopenic patients: a randomized, prospective study]". Gan to Kagaku Ryoho. 19 (9): 1315–20. PMID 1503486.
This article is issued from Wikipedia - version of the 5/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.